HORIBA Announces New Combined Raman Products With Cytoviva, Inc.

06/10/2020 |   Press Release More powerful nanoparticle analysis with Raman spectroscopy, hyperspectral imaging and enhanced darkfield illumination on the same microscope platform. Piscataway, NJ and Auburn, AL  – June 10th, 2020  HORIBA Scientific, global leader in measurement and analysis solutions for research and industry, and world leader in Raman spectroscopy, announces combined products using leading technology from CytoViva, Inc. By... Read more

Bio-Techne and Zero – The End of Prostate Cancer Announce Partnership to Fund Education and Awareness Campaigns to Empower Men With Prostate Cancer

MINNEAPOLIS, June 11, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with ZERO – The End of Prostate Cancer, the leading national nonprofit organization in the fight against prostate cancer. ZERO advances research, improves the lives of men and families, and inspires action for patients,... Read more

Promega Microsatellite Instability Molecular Test, OncoMate™ MSI Dx Analysis System, CE Marked and Available in Europe

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers Leiden, Netherlands and Madison, WI USA. (June 9, 2020) Promega Corporation today announced CE marking for the OncoMate™ MSI Dx Analysis System(OncoMate™ MSI) as a new in vitro diagnostic (IVD) medical device in Europe.... Read more

Bio-Techne Announces Release of GMP ProDots Proteins to Support Cell and Gene Therapy Manufacturing Workflows

MINNEAPOLIS, June 8, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the release of GMP ProDots™ Proteins to support cell and gene therapy manufacturing workflows. GMP ProDots™ Proteins address a critical need to precisely dose and safely add essential proteins such as growth factors and cytokines to therapeutic cell cultures. GMP ProDots Proteins, produced under GMP-grade conditions... Read more

Swift Biosciences and Arbor Biosciences Partner on Targeted NGS Workflows for Coronavirus

ANN ARBOR, Mich. June 3, 2020 /PRNewswire/ — Swift Biosciences and Arbor Biosciences, a division of Chiral Technologies, jointly announced a partnership to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. An enabling offering for epidemiological research and public health surveillance, the partnership leverages Swift’s patented Adaptase® technology... Read more

Swift Biosciences and Arbor Biosciences Partner on Targeted NGS Workflows for Coronavirus

ANN ARBOR, Mich. June 3, 2020 /PRNewswire/ — Swift Biosciences and Arbor Biosciences, a division of Chiral Technologies, jointly announced a partnership to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. An enabling offering for epidemiological research and public health surveillance, the partnership leverages Swift’s patented Adaptase® technology... Read more

SCIEX presents Echo MS System at ASMS Reboot

Echo® MS System delivers ultra-high throughput screening to redefine high-throughput quantification of molecules June 02, 2020 Framingham, MA — SCIEX, a global leader in life science analytical technologies, presents the Echo® MS System at ASMS Reboot 2020. Now commercially available, this system harnesses proprietary Acoustic Ejection Mass Spectrometry technology with the Open Port Interface to set a new... Read more

Rigaku Allies With JEOL to Jointly Develop an Integrated MicroED Platform

✓    Rigaku and JEOL will unify their core technologies—Rigaku’s high-speed, high-sensitivity photon-counting detector (HPC) and state-of-the-art single crystal software, and JEOL’s  transmission electron microscope—to create an integrated MicroED platform providing one-step structure solutions with electron crystallography. ✓    The resulting MicroED platform, based on the synergistic collaboration of both companies, will provide a solution for the... Read more

Swift Biosciences Enables COVID-19 Surveillance With NGS of Low Titer SARS-CoV-2 Specimens

ANN ARBOR, Mich. – May 28, 2020 — Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has announced the release of its Swift Normalase™ Amplicon Panel (SNAP) SARS-CoV-2 kit. Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift’s... Read more